Chronic myelogenous leukemia electrocardiogram: Difference between revisions
Badria Munir (talk | contribs) No edit summary |
Shyam Patel (talk | contribs) No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Chronic myelogenous leukemia | {{Chronic myelogenous leukemia}} | ||
{{CMG}} | {{CMG}} {{shyam}} {{AE}} {{Badria}} | ||
==Overview== | ==Overview== | ||
There are no | There are no specific EKG findings in chronic myelogenous leukemia. | ||
==Electrocardiogram== | ==Electrocardiogram== | ||
There are no specific EKG findings in chronic myelogenous leukemia. However, EKG may be necessary for patients receiving nilotinib, as this can cause cardiac toxicity and peripheral vascular disease.<ref name="pmid22271904">{{cite journal| author=Kim TD, le Coutre P, Schwarz M, Grille P, Levitin M, Fateh-Moghadam S et al.| title=Clinical cardiac safety profile of nilotinib. | journal=Haematologica | year= 2012 | volume= 97 | issue= 6 | pages= 883-9 | pmid=22271904 | doi=10.3324/haematol.2011.058776 | pmc=3366654 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=22271904 }} </ref> | |||
There are no | |||
==References== | ==References== | ||
{{ | {{reflist|2}} | ||
[[Category:Disease]] | |||
[[Category:Types of cancer]] | |||
[[Category:Hematology]] | |||
{{ | {{WikiDoc Help Menu}} | ||
{{ | {{WikiDoc Sources}} | ||
[[Category:Up-To-Date]] | |||
[[Category:Oncology]] | |||
[[Category:Medicine]] | |||
[[Category:Hematology]] | |||
[[Category:Immunology]] | |||
Latest revision as of 18:06, 28 December 2018
|
Chronic myelogenous leukemia Microchapters |
|
Differentiating Chronic myelogenous leukemia from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Chronic myelogenous leukemia electrocardiogram On the Web |
|
American Roentgen Ray Society Images of Chronic myelogenous leukemia electrocardiogram |
|
Directions to Hospitals Treating Chronic myelogenous leukemia |
|
Risk calculators and risk factors for Chronic myelogenous leukemia electrocardiogram |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Shyam Patel [2] Associate Editor(s)-in-Chief: Badria Munir M.B.B.S.[3]
Overview
There are no specific EKG findings in chronic myelogenous leukemia.
Electrocardiogram
There are no specific EKG findings in chronic myelogenous leukemia. However, EKG may be necessary for patients receiving nilotinib, as this can cause cardiac toxicity and peripheral vascular disease.[1]
References
- ↑ Kim TD, le Coutre P, Schwarz M, Grille P, Levitin M, Fateh-Moghadam S; et al. (2012). "Clinical cardiac safety profile of nilotinib". Haematologica. 97 (6): 883–9. doi:10.3324/haematol.2011.058776. PMC 3366654. PMID 22271904.